Eiger BioPharmaceuticals, Inc.
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
Last updated:
Abstract:
Tipifarnib or a tipifarnib derivative is used to treat HDV infection as a monotherapy or in combination with an interferon and/or boosting agent such as a CYP3A4 inhibitor such as ritonavir and cobicistat.
Status:
Application
Type:
Utility
Filling date:
10 Mar 2021
Issue date:
27 Jan 2022